{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T23:01:00Z","timestamp":1792364460104,"version":"4.4.0"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T00:00:00Z","timestamp":1617667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Using a targeted transcriptomics approach, we have analyzed resected brain tissue from a cohort of 53 pediatric epilepsy surgery cases, and have found that there is a spectrum of involvement of both the innate and adaptive immune systems as evidenced by the differential expression of immune-specific genes in the affected brain tissue. The specimens with the highest expression of immune-specific genes were from two Rasmussen encephalitis cases, which is known to be a neuro-immunological disease, but also from tuberous sclerosis complex (TSC), focal cortical dysplasia, and hemimegalencephaly surgery cases. We obtained T cell receptor (TCR) V\u03b2 chain sequence data from brain tissue and blood from patients with the highest levels of T cell transcripts. The clonality indices and the frequency of the top 50 V\u03b2 clonotypes indicated that T cells in the brain were clonally restricted. The top 50 V\u03b2 clonotypes comprised both public and private (patient specific) clonotypes, and the TCR V\u03b2 chain third complementarity region (CDR3) of the most abundant public V\u03b2 clonotype in each brain sample was strikingly similar to a CDR3 that recognizes an immunodominant epitope in either human cytomegalovirus or Epstein Barr virus, or influenza virus A. We found that the frequency of 14 of the top 50 brain V\u03b2 clonotypes from a TSC surgery case had significantly increased in brain tissue removed to control recurrent seizures 11 months after the first surgery. Conversely, we found that the frequency in the blood of 18 of the top 50 brain clonotypes from a second TSC patient, who was seizure free, had significantly decreased 5 months after surgery indicating that T cell clones found in the brain had contracted in the periphery after removal of the brain area associated with seizure activity and inflammation. However, the frequency of a public and a private clonotype significantly increased in the brain after seizures recurred and the patient underwent a second surgery. Combined single cell gene expression and TCR sequencing of brain-infiltrating leukocytes from the second surgery showed that the two clones were CD8 effector T cells, indicating that they are likely to be pathologically relevant.<\/jats:p>","DOI":"10.3389\/fimmu.2021.664344","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T08:51:36Z","timestamp":1617699096000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Clonally Focused Public and Private T Cells in Resected Brain Tissue From Surgeries to Treat Children With Intractable Seizures"],"prefix":"10.3389","volume":"12","author":[{"given":"Julia W.","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel D.","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Faure-Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandi K.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Lawlor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Leventer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"Lew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Lockhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Pope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard L.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Salamon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry V.","family":"Vinters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary W.","family":"Mathern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aria","family":"Fallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey C.","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/epi.13784","article-title":"Innate and adaptive immunity in human epilepsies","author":"Bauer","year":"2017","journal-title":"Epilepsia"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-018-1215-5","article-title":"Viral triggers and inflammatory mechanisms in pediatric epilepsy","volume":"56","author":"Bartolini","year":"2019","journal-title":"Mol Neurobiol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/epi.14626","article-title":"Infections and risk of epilepsy in children and young adults: A nationwide study","volume":"60","author":"Ahlers","year":"2019","journal-title":"Epilepsia"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/epi.16571","article-title":"Acute symptomatic seizures secondary to autoimmune encephalitis and autoimmune-associated epilepsy: Conceptual definitions","volume":"61","author":"Steriade","year":"2020","journal-title":"Epilepsia"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.11.106","article-title":"Somatic mutations activating the mTOR pathway in dorsal telencephalic progenitors cause a continuum of cortical dysplasias","volume":"21","author":"D\u2019Gama","year":"2017","journal-title":"Cell Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-genom-083118-015354","article-title":"Genetic etiologies, diagnosis, and treatment of tuberous sclerosis complex","volume":"20","author":"Salussolia","year":"2019","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.eplepsyres.2007.10.002","article-title":"Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex","volume":"78","author":"Boer","year":"2008","journal-title":"Epilepsy Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2010.02547.x","article-title":"Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias","volume":"51","author":"Iyer","year":"2010","journal-title":"Epilepsia"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2010.02777.x","article-title":"The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission","volume":"52","author":"Blumcke","year":"2011","journal-title":"Epilepsia"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20171285","article-title":"Peripherally derived T regulatory and gammadelta T cells have opposing roles in the pathogenesis of intractable pediatric epilepsy","volume":"215","author":"Xu","year":"2018","journal-title":"J Exp Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00121","article-title":"Evidence for innate and adaptive immune responses in a cohort of intractable pediatric epilepsy surgery patients","volume":"10","author":"Owens","year":"2019","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201646837","article-title":"CD69: from activation marker to metabolic gatekeeper","volume":"47","author":"Cibrian","year":"2017","journal-title":"Eur J Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v025.i01","article-title":"FactoMineR: An R package for multivariate analysis","volume":"25","author":"Le","year":"2008","journal-title":"J Stat Softw"},{"key":"B14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0145-305X(02)00039-3","article-title":"IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains","volume":"27","author":"Lefranc","year":"2003","journal-title":"Dev Comp Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"460","DOI":"10.12688\/f1000research.6756.1","article-title":"Deep sequencing of the T-cell receptor repertoire demonstrates polyclonal T-cell infiltrates in psoriasis","volume":"4","author":"Harden","year":"2015","journal-title":"F1000Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/sim.2832","article-title":"Chi-squared and Fisher-Irwin tests of two-by-two tables with small sample recommendations","volume":"26","author":"Campbell","year":"2007","journal-title":"Stat Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz874","article-title":"VDJdb in 2019: database extension, new analysis infrastructure and a T-cell receptor motif compendium","volume":"48","author":"Bagaev","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12974-015-0352-2","article-title":"Evidence for the involvement of gamma delta T cells in the immune response in Rasmussen encephalitis","volume":"12","author":"Owens","year":"2015","journal-title":"J Neuroinflamm"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/82_2014_364","article-title":"Cytobank: providing an analytics platform for community cytometry data analysis and collaboration","volume":"377","author":"Chen","year":"2014","journal-title":"Curr Top Microbiol Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e1005112","DOI":"10.1371\/journal.pcbi.1005112","article-title":"Cytofkit: A Bioconductor package for an integrated mass cytometry data analysis pipeline","volume":"12","author":"Chen","year":"2016","journal-title":"PloS Comput Biol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00064","article-title":"Evidence for resident memory T cells in Rasmussen Encephalitis","volume":"7","author":"Owens","year":"2016","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-18-0342","article-title":"Immune cell gene signatures for profiling the microenvironment of solid tumors","volume":"6","author":"Nirmal","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/glia.23572","article-title":"A core transcriptional signature of human microglia: Derivation and utility in describing region-dependent alterations associated with Alzheimer\u2019s disease","volume":"67","author":"Patir","year":"2019","journal-title":"Glia"},{"key":"B25","doi-asserted-by":"publisher","first-page":"4706","DOI":"10.1038\/s41467-019-12464-3","article-title":"Single-cell transcriptomics of human T cells reveals tissue and activation signatures in health and disease","volume":"10","author":"Szabo","year":"2019","journal-title":"Nat Commun"},{"key":"B26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/00019052-200204000-00012","article-title":"Rasmussen\u2019s encephalitis: a role for autoimmune cytotoxic T lymphocytes","volume":"15","author":"Bauer","year":"2002","journal-title":"Curr Opin Neurol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/j.0013-9580.2004.33103.x","article-title":"The pathology of Rasmussen syndrome: stages of cortical involvement and neuropathological studies in 45 hemispherectomies","volume":"45","author":"Pardo","year":"2004","journal-title":"Epilepsia"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/BF00309624","article-title":"Chronic encephalitis associated with epilepsy: immunohistochemical and ultrastructural studies","volume":"89","author":"Farrell","year":"1995","journal-title":"Acta Neuropathol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/imr.12666","article-title":"iReceptor: A platform for querying and analyzing antibody\/B-cell and T-cell receptor repertoire data across federated repositories","volume":"284","author":"Corrie","year":"2018","journal-title":"Immunol Rev"},{"key":"B30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12896-017-0379-9","article-title":"Overview of methodologies for T-cell receptor repertoire analysis","volume":"17","author":"Rosati","year":"2017","journal-title":"BMC Biotechnol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00608","article-title":"Shared HLA Class I and II alleles and clonally restricted public and private brain-infiltrating alpha beta T cells in a cohort of Rasmussen encephalitis surgery patients","volume":"7","author":"Dandekar","year":"2016","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1998.38398222871.x","article-title":"Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time","volume":"38","author":"Larsson","year":"1998","journal-title":"Transfusion"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00980-19","article-title":"Epstein-Barr virus-specific CD8 T cells selectively infiltrate the brain in multiple sclerosis and interact locally with virus-infected cells: clue for a virus-driven immunopathological mechanism","volume":"93","author":"Serafini","year":"2019","journal-title":"J Virol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)91292-0","article-title":"Epstein-Barr virus in brain and Rasmussen\u2019s encephalitis","volume":"1","author":"Walter","year":"1989","journal-title":"Lancet"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)92965-K","article-title":"Cytomegalovirus and Rasmussen\u2019s encephalitis","volume":"336","author":"Power","year":"1990","journal-title":"Lancet"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(93)90137-6","article-title":"Herpesviruses in chronic encephalitis associated with intractable childhood epilepsy","volume":"24","author":"Vinters","year":"1993","journal-title":"Hum Pathol"},{"key":"B37","first-page":"7","article-title":"Rasmussen\u2019s syndrome: a study of potential viral etiology","volume":"14","author":"Atkins","year":"1995","journal-title":"Clin Neuropathol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.45.1.108","article-title":"Chronic encephalitis and epilepsy (Rasmussen\u2019s encephalitis): detection of cytomegalovirus and herpes simplex virus 1 by the polymerase chain reaction and in situ hybridization","volume":"45","author":"Jay","year":"1995","journal-title":"Neurology"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.4.925","article-title":"Treatment of Rasmussen\u2019s syndrome with ganciclovir","volume":"47","author":"McLachlan","year":"1996","journal-title":"Neurology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/microbiolspec.DMIH2-0022-2015","article-title":"Cytomegalovirus","volume":"4","author":"Dioverti","year":"2016","journal-title":"Microbiol Spectr"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1542\/pir.32-9-375","article-title":"Epstein-Barr virus","volume":"32","author":"Jenson","year":"2011","journal-title":"Pediatr Rev"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2007.11.014","article-title":"Human cytomegalovirus: Latency and reactivation in the myeloid lineage","volume":"41","author":"Sinclair","year":"2008","journal-title":"J Clin Virol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-014-8496-1","article-title":"The interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and disease","volume":"58","author":"Hatton","year":"2014","journal-title":"Immunol Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1096\/fj.09-136200","article-title":"CD8+ T cells and neuronal damage: direct and collateral mechanisms of cytotoxicity and impaired electrical excitability","volume":"23","author":"Melzer","year":"2009","journal-title":"FASEB J"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20122143","article-title":"Neuroprotective intervention by interferon-gamma blockade prevents CD8+ T cell-mediated dendrite and synapse loss","volume":"210","author":"Kreutzfeldt","year":"2013","journal-title":"J Exp Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2015.00163","article-title":"CD8(+) T Cell-Mediated Neuronal Dysfunction and Degeneration in Limbic Encephalitis","volume":"6","author":"Ehling","year":"2015","journal-title":"Front Neurol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.cell.2018.07.049","article-title":"Neurons under T cell attack coordinate phagocyte-mediated synaptic stripping","volume":"175","author":"Di Liberto","year":"2018","journal-title":"Cell"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00966","article-title":"\u201cImmune TOR-opathies,\u201d a novel disease entity in clinical immunology","volume":"9","author":"Jung","year":"2018","journal-title":"Front Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.04.028","article-title":"MenTORing Immunity: mTOR signaling in the development and function of tissue-resident immune cells","volume":"46","author":"Jones","year":"2017","journal-title":"Immunity"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2017.04.005","article-title":"mTOR signaling in the differentiation and function of regulatory and effector T cells","volume":"46","author":"Zeng","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003400","article-title":"Long-term treatment of epilepsy with everolimus in tuberous sclerosis","volume":"87","author":"Krueger","year":"2016","journal-title":"Neurology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1471-2377-10-84","article-title":"Treatment of refractory epilepsy with natalizumab in a patient with multiple sclerosis","volume":"10","author":"Sotgiu","year":"2010","journal-title":"Case Rep BMC Neurol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31829c5ceb","article-title":"Rasmussen encephalitis treated with natalizumab","volume":"81","author":"Bittner","year":"2013","journal-title":"Neurology"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12042","article-title":"Rasmussen encephalitis: incidence and course under randomized therapy with tacrolimus or intravenous immunoglobulins","volume":"54","author":"Bien","year":"2013","journal-title":"Epilepsia"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S65558","article-title":"Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerations","volume":"12","author":"Ayzenberg","year":"2016","journal-title":"Ther Clin Risk Manag"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13387","article-title":"Anti-tumor necrosis factor alpha therapy (adalimumab) in Rasmussen\u2019s encephalitis: An open pilot study","volume":"57","author":"Lagarde","year":"2016","journal-title":"Epilepsia"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.664344\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T08:51:41Z","timestamp":1617699101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.664344\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,6]]},"references-count":56,"alternative-id":["10.3389\/fimmu.2021.664344"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.664344","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,6]]},"article-number":"664344"}}